Olfactory dysfunction, including parosmia, has been associated with liraglutide use 46 , likely reflecting GLP-1R-mediated modulation of odor-evoked insulin secretion and foraging behaviors in the olfactory bulb 51,52
Vomiting, diarrhea, constipation, and abdominal discomfort are also reported
All of this aligns well with how consumers increasingly want to manage weight and metabolic health over time. New England Consulting Groups Stibel notes that the beverage market already has seen the influence that GLP-1 agonists have had on product development
Reconstitution B: 5 mg vial + 1 mL BAC water (5 mg/mL) half the volume per dose, useful when a 2.4 mg target would otherwise approach the syringe limit
What works brilliantly for your mate with oily skin might leave your dry skin feeling tight and uncomfortable
This underscores that tirzepatide is a long term maintenance therapy, not just a short term weight loss tool